Content Source:
Office of Public Health Data, Surveillance, and Technology
Anthrax (Bacillus anthracis)
1990 Case Definition
Anthrax (Bacillus anthracis)
1990 Case Definition
1990 Case Definition
Clinical Description
An illness with acute onset characterized by several distinct clinical forms including:
- Cutaneous: a skin lesion evolving over 2 to 6 days from a papule, through a vesicular stage, to a depressed black eschar
- Inhalation: a brief prodrome resembling a viral respiratory illness followed by development of hypoxia and dyspnea, with x-ray evidence of mediastinal widening
- Intestinal: severe abdominal distress followed by fever and signs of septicemia
- Oropharyngeal: mucosal lesion in the oral cavity or oropharynx, cervical adenopathy and edema, and fever
Laboratory Criteria For Diagnosis
- Isolation of Bacillus anthracis from a clinical specimen, OR
- Fourfold or greater rise in either the anthrax enzyme-linked immunosorbent assay (ELISA) or electrophoretic immunotransblot (EITB) titer between acute- and convalescent-phase serum specimens obtained greater than or equal to 2 weeks apart, OR
- Anthrax ELISA titer greater than or equal to 64 or an EITB reaction to the protective antigen and/or lethal factor bands in one or more serum samples obtained after onset of symptoms, OR
- Demonstration of B. anthracis in a clinical specimen by immunofluorescence
Case Classification
Confirmed
A clinically compatible illness that is laboratory confirmed